CoChat

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

van Dieren, S., Czernichow, S., Chalmers, J., Kengne, A. P., de Galan, B. E., Poulter, N., Woodward, M., Beulens, J. W. J., Grobbee, D. E., van der Schouw, Y. T., Zoungas, S. · 2012 · Diabetes, Obesity and Metabolism
Cited by 50

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims: To determine the baseline characteristics and glucose‐lowering therapies associated with weight change among patients with type 2 diabetes. Methods: Eleven thousand one hundred and forty participants in the ADVANCE trial were randomly assigned to an intensive [aiming for a haemoglobin A1c (HbA1c) ≤6.5%] or a standard blood glucose‐control strategy. Weight was measured at baseline and every 6 months over a median follow‐up of 5 years. Multivariable linear regression and linear‐mixed effect models were used to examine predictors of weight change. Results: The mean difference in weight between the intensive and standard glucose‐control arm during follow‐up was 0.75 kg (95% CI: 0.56–0.94), p‐value <0.001. The mean weight decreased by 0.70 kg (95% CI: 0.53–0.87), p < 0.001 by the end of follow‐up in the standard arm but remained stable in the intensive arm, with a non‐significant gain of 0.16 kg (95% CI: −0.02 to 0.34), p = 0.075. Baseline factors associated with weight gain were younger age, higher HbA1c, Caucasian ethnicity and number of glucose‐lowering medications. Treatment combinations including insulin [3.22 kg (95% CI: 2.92–3.52)] and thiazolidinediones [3.06 kg (95% CI: 2.69–3.43)] were associated with the greatest weight gain while treatment combinations including sulphonylureas were associated with less weight gain [0.71 kg (95%CI: 0.39–1.03)]. Conclusions: Intensive glucose‐control regimens are not necessarily associated with substantial weight gain. Patient characteristic associated with weight change were age, ethnicity, smoking and HbA1c. The main treatment strategies predicting weight gain were the use of insulin and thiazolidinediones.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2012.01556.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 50

Metadata

Authors
van Dieren, S., Czernichow, S., Chalmers, J., Kengne, A. P., de Galan, B. E., Poulter, N., Woodward, M., Beulens, J. W. J., Grobbee, D. E., van der Schouw, Y. T., & Zoungas, S.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2012-02-08
Volume
14
Issue
5
Pages
464-469
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2083260646
Cited by
50
References
4
FWCI
3.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial. https://app.cochat.ai/papers/10.1111/j.1463-1326.2012.01556.x
The paper
van Dieren, S., Czernichow, S., Chalmers, J., Kengne, A. P., de Galan, B. E., Poulter, N., Woodward, M., Beulens, J. W. J., Grobbee, D. E., van der Schouw, Y. T., & Zoungas, S. (2012). Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2012.01556.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.